BRPI0713826A2 - Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3 - Google Patents

Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3

Info

Publication number
BRPI0713826A2
BRPI0713826A2 BRPI0713826A BRPI0713826A2 BR PI0713826 A2 BRPI0713826 A2 BR PI0713826A2 BR PI0713826 A BRPI0713826 A BR PI0713826A BR PI0713826 A2 BRPI0713826 A2 BR PI0713826A2
Authority
BR
Brazil
Prior art keywords
receptor antagonists
muscarinic receptor
quinuclidine derivatives
quinuclidine
derivatives
Prior art date
Application number
Other languages
English (en)
Inventor
Gabriele Amari
Andrea Rizzi
Riccardo Patacchini
Valentina Cenacchi
Gino Villetti
Juan Lorenzo Catena Ruiz
Isabel Masip Masip
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BRPI0713826A2 publication Critical patent/BRPI0713826A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0713826 2006-07-26 2007-07-23 Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3 BRPI0713826A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06117883A EP1882691A1 (en) 2006-07-26 2006-07-26 Quinuclidine derivatives as M3 antagonists
PCT/EP2007/057585 WO2008012290A2 (en) 2006-07-26 2007-07-23 Quinuclidine derivatives as m3 antagonists

Publications (1)

Publication Number Publication Date
BRPI0713826A2 true BRPI0713826A2 (pt) 2015-05-12

Family

ID=37890216

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0713826 BRPI0713826A2 (pt) 2006-07-26 2007-07-23 Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3

Country Status (16)

Country Link
US (1) US7838534B2 (pt)
EP (2) EP1882691A1 (pt)
JP (1) JP5331688B2 (pt)
KR (1) KR20090033443A (pt)
CN (1) CN101490049A (pt)
AR (1) AR062104A1 (pt)
AU (1) AU2007278231B2 (pt)
BR (1) BRPI0713826A2 (pt)
CA (1) CA2658649A1 (pt)
CL (1) CL2007002159A1 (pt)
EA (1) EA017698B1 (pt)
MX (1) MX2009000999A (pt)
PE (1) PE20080407A1 (pt)
TW (1) TW200817398A (pt)
WO (1) WO2008012290A2 (pt)
ZA (1) ZA200901124B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ526580A (en) 2000-12-22 2005-04-29 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as M3 antagonists
ES2246170B1 (es) * 2004-07-29 2007-04-01 Almirall Prodesfarma, S.A. Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.
EP2080507A1 (en) * 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Pharmaceutical formulations comprising an anticholinergic drug
EP2080523A1 (en) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Compositions comprising an antimuscarinic and a long-acting beta-agonist
EP2080508A1 (en) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Dry powder formulation comprising an anticholinergic drug
EP2154136A1 (en) * 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Quinuclidine carbonate derivatives and medicinal compositions thereof
EP2206712A1 (en) * 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
BR112012032332A2 (pt) 2010-06-22 2016-11-08 Chiesi Farma Spa composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo
JP2013529606A (ja) * 2010-06-22 2013-07-22 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 抗ムスカリン薬含有乾燥粉末配合物
BR112012031967A2 (pt) 2010-06-22 2019-09-24 Chiesi Farm Spa composto, uso de um composto, combinação de um composto e composição farmacêutica
EP2585457B1 (en) * 2010-06-22 2015-07-22 Chiesi Farmaceutici S.p.A. Alkaloid aminoester derivatives and medicinal composition thereof
WO2012069275A1 (en) 2010-11-26 2012-05-31 Chiesi Farmaceutici S.P.A. Glycine derivatives and their use as muscarinic receptor antagonists
US20120220557A1 (en) 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
CA2834467A1 (en) 2011-04-29 2012-11-01 Chiesi Farmaceutici S.P.A. Alkaloid ester and carbamate derivatives and medicinal compositions thereof
BR112014013179A2 (pt) 2011-12-30 2017-06-13 Chiesi Farm Spa compostos, combinação de um composto, composição farmacêutica e usos de um composto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100751981B1 (ko) * 2000-06-27 2007-08-28 라보라토리오스 살바트, 에스.에이. 아릴알킬아민으로부터 유도된 카바메이트
NZ526580A (en) * 2000-12-22 2005-04-29 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as M3 antagonists
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
JP4505227B2 (ja) * 2001-12-20 2010-07-21 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ １−アルキル−１−アゾニアビシクロ［２．２．２］オクタンカルバメート誘導体およびムスカリンレセプターアンタゴニストとしてのそれらの使用
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
AR062104A1 (es) 2008-10-15
TW200817398A (en) 2008-04-16
EP1882691A1 (en) 2008-01-30
KR20090033443A (ko) 2009-04-03
WO2008012290A2 (en) 2008-01-31
AU2007278231A1 (en) 2008-01-31
EA200970158A1 (ru) 2009-06-30
JP5331688B2 (ja) 2013-10-30
CN101490049A (zh) 2009-07-22
AU2007278231B2 (en) 2012-08-16
JP2009544659A (ja) 2009-12-17
CA2658649A1 (en) 2008-01-31
PE20080407A1 (es) 2008-06-17
EA017698B1 (ru) 2013-02-28
US7838534B2 (en) 2010-11-23
US20080039493A1 (en) 2008-02-14
CL2007002159A1 (es) 2008-01-04
EP2049533A2 (en) 2009-04-22
ZA200901124B (en) 2010-05-26
WO2008012290A3 (en) 2008-03-13
MX2009000999A (es) 2009-04-15

Similar Documents

Publication Publication Date Title
BRPI0713826A2 (pt) Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3
BRPI0812981A2 (pt) Derivados de piperidina úteis como antagonistas dos receptores de orexina
ATE555111T1 (de) Chinuclidinol-derivate als muscarinrezeptor- antagonisten
BRPI0817245A2 (pt) Derivados e quinolina como antagonistas receptores de 5ht5a
ATE540942T1 (de) Imidazolderivate als ccr2-rezeptor-antagonisten
BRPI0919844A2 (pt) compostos de azaindazol como antagonistas do receptor ccr1
DK2081951T3 (da) Progesteron-receptorantagonister
BRPI0717023A2 (pt) Tiazol pirazolopirimidina como antagonistas do receptor de crf1
BRPI0717937A2 (pt) Compostos de pirazona como antagonistas do receptor mineralocorticóide
ATE509022T1 (de) Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide
BRPI0810462A2 (pt) Derivados de quinolina-carboxamida como antagonistas de p2y12
BRPI0909157A2 (pt) compostos heterocíclicos como antagonistas de receptores de adenosina
BRPI0911563A2 (pt) uso de antagonista da progesterona
BRPI0815948A2 (pt) "compostos heterocíclicos como antagonistas de receptorncrth2"
DK2252581T3 (da) Kappa-selektiv opioidreceptorantagonist
EP2350060A4 (en) Melanocortin receptor AGONISTS
BRPI0815797A2 (pt) Compostos 8-azabiciclo[3.2.1]octil-2-hidroxibanzamida como antagonistas de receptor opióide mu
BRPI0718494A2 (pt) Derivado de fenilsulfamoil benzamida como antagonistas de bradicinina
BRPI0817061A2 (pt) Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3
BRPI0814767A2 (pt) Derivados de monoamida como antagonistas do receptor de orexina
BRPI0822693A2 (pt) Derivados de quinuclidina como antagonistas do receptor muscarínico m3
BRPI0807615A2 (pt) compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico
BRPI0718436A2 (pt) Novos derivados de benzamida como antagonistas da bradicina
BRPI0918985A2 (pt) derivados de benzo[d]isoxazol-3-il-piperazina úteis como moduladores dos receptores d3 de dopamina
BRPI0720078A2 (pt) 2-aminoquinolinas como antagonistas de receptores de 5-ht(5a)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.